1. Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, and
2. Blood Research Laboratory, National Blood Service, John Radcliffe Hospital, Headington, Oxford, United Kingdom;
3. Departments of Paediatrics and
4. Internal Medicine, Siriraj-Thalassemia Research Program and World Health Organization Collaborating Center for the Control of Haemoglobinopathies, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand;
5. Department of Biochemistry, Faculty of Medicine, Chang Mai University, Chang Mai, Thailand;
6. Departments of Biochemistry,
7. Haematology, and
8. Endocrinology, Macclesfield Hospital, Macclesfield, United Kingdom;
9. Departments of Medicine and
10. Pharmacology, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka;
11. Clinical Genetics, Birmingham Women's Hospital, Birmingham, United Kingdom;
12. Renal Unit and
13. Clinical Chemistry, New Cross Hospital, Wolverhampton, United Kingdom;
14. Research Institute, Healthcare Sciences, Wolverhampton University, Wolverhampton, United Kingdom;
15. Regional Genetic Service and Medical Genetic Research Group, St Mary's Hospital, Central Manchester and Manchester Children's Hospital National Health Service (NHS) Trust, Manchester, United Kingdom;
16. Royal Blackburn Hospital, Blackburn, United Kingdom; and
17. Kettering General Hospital NHS Foundation Trust, Kettering, United Kingdom